Progressive change of intra-islet GLP-1 production during diabetes development.

Progressive change of intra-islet GLP-1 production during diabetes development.
复制标题

DOI:
10.1002/dmrr.2534
复制
发表时间:
2014-11
影响因子:
8
通讯作者:
Wu, Hongju
Wu, Hongju
中科院分区:
医学2区
文献类型:
--
作者:
O'Malley, Thomas J.;Fava, Genevieve E.;Zhang, Yanqing;Fonseca, Vivian A.;Wu, Hongju

文献摘要

参考文献

被引文献

相似文献

胰高血糖素样肽1(GLP-1)和胰高血糖素具有相同的前体分子原胰高血糖素,但各自以组织特异性的方式来自不同的翻译后过程。最近的研究表明,在胰岛细胞中,GLP-1与胰高血糖素共表达。本研究旨在探讨GLP-1与胰岛高血糖素在糖尿病发生发展过程中的渐进性变化。本研究采用1型(NOD小鼠)和2型(db/db小鼠)糖尿病模型。这些小鼠被密切监测其糖尿病进展情况,并根据它们的血糖水平在不同的阶段被处死。免疫组织化学方法检测大鼠胰岛GLP-1和胰高血糖素的表达。定量分析以评估这些变化的意义。在db/db小鼠中,随着糖尿病的发展,胰岛中表达GLP-1的细胞与表达胰高血糖素的细胞的比率呈显著的进行性增加。GLP-1表达增加与PC1/3表达上调相一致。有趣的是,在NOD小鼠的1型糖尿病发展过程中,胰岛内GLP-1的表达没有明显变化。这项研究表明,在2型糖尿病的发展过程中,GLP-1在胰岛中的表达逐渐上调。此外,数据还表明,1型和2型糖尿病患者胰岛内GLP-1的产生存在明显差异。这些差异可能会对这些疾病的临床和病理生理过程产生影响,并可能成为治疗方法的目标。
Glucagon-like Peptide 1 (GLP-1) and glucagon shares the same precursor molecule proglucagon, but each arises from a distinct posttranslational process in a tissue-specific manner. Recently it has been shown that GLP-1 is co-expressed with glucagon in pancreatic islet cells. This study was aimed to investigate the progressive changes of GLP-1 vs glucagon production in pancreatic islets during the course of diabetes development. Both type 1 (NOD mice) and type 2 (db/db mice) diabetes models were employed in this study. The mice were monitored closely for their diabetes progression, and were sacrificed at different stages according to their blood glucose levels. GLP-1 and glucagon expression in the pancreatic islets was examined using immunohistochemistry assays. Quantitative analysis was performed to evaluate the significance of the changes. The ratio of GLP-1-expressing cells to glucagon expressing cells in the islets showed significant, progressive increase with the development of diabetes in db/db mice. The increase of GLP-1 expression was in accordance with the upregulation of PC1/3 expression in these cells. Interestingly, intra-islet GLP-1 expression was not significantly changed during the development of type 1 diabetes in NOD mice. The study demonstrated GLP-1 was progressively up-regulated in pancreatic islets during type 2 diabetes development. In addition, the data suggest clear differences in intra-islet GLP-1 production between type 1 and type 2 diabetes developments. These differences may have an impact on the clinical and pathophysiological processes of these diseases and may be a target for therapeutic approaches.
DOI: 10.1074/jbc.270.44.26488
发表时间: 1995-11-03
影响因子: 4.8
作者:
ROUILLE, Y;MARTIN, S;STEINER, DF
通讯作者: STEINER, DF
DOI: 10.1007/s00125-011-2080-1
发表时间: 2011-06-01
期刊: DIABETOLOGIA
影响因子: 8.2
作者:
Hansen, A. M. K.;Boedvarsdottir, T. B.;Karlsen, A. E.
通讯作者: Karlsen, A. E.
DOI: 10.2337/diabetes.54.7.2212
发表时间: 2005-07-01
期刊: DIABETES
影响因子: 7.7
作者:
Meier, JJ;Kemmeries, G;Nauck, MA
通讯作者: Nauck, MA
DOI: 10.1210/jc.2008-0605
发表时间: 2008-12-01
影响因子: 5.8
作者:
Salehi, Marzieh;Vahl, Torsten P.;D'Alessio, David A.
通讯作者: D'Alessio, David A.
DOI: 10.1074/jbc.273.6.3431
发表时间: 1998-02-06
影响因子: 4.8
作者:
Furuta, M;Carroll, R;Steiner, DF
通讯作者: Steiner, DF